MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12871-026-03999-2

Медицинская библиотека · BMC anesthesiology · 2026

Residual gastric content after holding of glucagon-like peptide-1 receptor agonists before elective surgery: a cross-sectional study - the RESIDUAL study.

Boudreau Charles, Couture Marjorie, Rousseau-Saine Nicolas, Laferrière-Langlois Pascal, Roy-Renaud Étienne, Burey Julien, Raymond Meggie, Denault André, Morisson Louis

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

INTRODUCTION

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are now increasingly used for glycemic control in type 2 diabetes mellitus as well as for weight loss. Their effect on gastric emptying may increase the risk of aspiration in the perioperative setting; unfortunately, the optimal schedule of perioperative holding of GLP-1 RA is unclear.

METHODS

We conducted a cross-sectional prospective study at two university affiliated hospitals in Montreal, Canada, comparing the preoperative prevalence of increased residual gastric content (RGC) on gastric ultrasound (GUS) between two groups of fasted adults scheduled for elective surgery: (i) an exposure group of patients receiving a weekly injectable GLP-1 RA and discontinued for ≥ 7 days before surgery, regardless of indication; and (ii) a control group of patients not receiving any GLP-1 RA, preferentially with type 2 diabetes or with a body mass index ≥ 25 kg/m². The primary outcome was increased RGC, defined as the presence of solid content, thick liquid, or > 1.5 mL/kg of clear liquid. Confounding was addressed using overlap-weighting propensity-score adjustment.

RESULTS

93 patients were included. The unadjusted prevalence of increased RGC was 24% (10/41) in the control group and 42% (22/52) in the exposure group. Solid content accounted for 80% (8/10) and 82% (18/22) of positive exams in the control group and the exposure group, respectively. In the unadjusted analysis, there was no statistically significant difference in increased RGC between groups (prevalence ratio, 1.73; 95% CI, 0.96 to 3.75). There was no statistically significant difference between groups after adjustment for confounding (adjusted prevalence ratio, 1.65; 95% CI, 0.7 to 3.7) with an absolute average treatment effect of 15.4% (95% CI, -10 to 35.6).

CONCLUSIONS

The prevalence of increased residual gastric content was 42% in patients who had discontinued weekly GLP-1 RA for at least 7 days, compared with 24% in non-exposed controls. Although this difference was not statistically significant, our study was underpowered. The findings therefore represent a clinically relevant but statistically inconclusive signal that the recommended 7-day discontinuation interval may not consistently restore an empty stomach in patients on weekly GLP-1 RA.

TRIAL REGISTRATION: This study was registered on clinicaltrials.gov (July 8th, 2024, NCT06500143).

Для цитирования: Boudreau Charles, Couture Marjorie, Rousseau-Saine Nicolas, Laferrière-Langlois Pascal, Roy-Renaud Étienne, Burey Julien, Raymond Meggie, Denault André, Morisson Louis. Residual gastric content after holding of glucagon-like peptide-1 receptor agonists before elective surgery: a cross-sectional study - the RESIDUAL study.. BMC anesthesiology. 2026. DOI: 10.1186/s12871-026-03999-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.